Hypofractionation for prostate cancer - In Response

被引：1
|
作者：
Brenner, DJ [1 ]
机构：
[1] Columbia Univ, Dept Radiat Oncol, Ctr Radiol Res, New York, NY 10027 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2001年 / 49卷 / 05期
关键词：
D O I：
10.1016/S0360-3016(00)01564-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1522 / 1523
页数：2
相关论文
共 50 条
  • [41] Rapid implementation of extreme hypofractionation protocols in prostate cancer using RapidPlan® in response to COVID-19
    Martell, Kevin
    McGeachy, Philip
    Quon, Harvey
    Quirk, Sarah
    Roumeliotis, Michael
    Husain, Siraj
    Meyer, Tyler
    Sia, Michael
    Thind, Kundan
    RADIOTHERAPY AND ONCOLOGY, 2020, 151 : 296 - 297
  • [42] Hypofractionation in Prostate Cancer: How Far Can We Go?
    Hoskin, P. J.
    CLINICAL ONCOLOGY, 2008, 20 (10) : 727 - 728
  • [43] Dose constraints validation in moderate hypofractionation in localized prostate cancer
    Maldonado, X.
    Altabas, M.
    Garre, J.
    Vazquez, M.
    Magrina, S.
    Delgado, A.
    Docampo, N.
    Geng, A.
    Hermida, M.
    Sanchez-Artuno, D.
    Giralt, J.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S1113 - S1114
  • [44] Investigating the Benefit of Combined Androgen Modulation and Hypofractionation in Prostate Cancer
    Zamagni, Alice
    Zanoni, Michele
    Cortesi, Michela
    Arienti, Chiara
    Pignatta, Sara
    Naldini, Antonella
    Sarnelli, Anna
    Romeo, Antonino
    Tesei, Anna
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (22) : 1 - 17
  • [45] Moderate or extreme hypofractionation and localized prostate cancer: The times are changing
    Krhili, S. Line
    Crehange, G.
    Albert-Dufrois, H.
    Guimas, V.
    Minsat, M.
    Supiot, S.
    CANCER RADIOTHERAPIE, 2019, 23 (6-7): : 503 - 509
  • [46] Hypofractionation Adoption in Prostate Cancer Radiotherapy: Results of an International Survey
    Sabbagh, Ali
    Weiss, Jessica
    Tawk, Bouchra
    Mohammed, Mohammed A.
    Abdulbaki, Hasan
    Moraes, Fabio Y.
    Grover, Surbhi
    Yap, Mei Ling
    Zubizarreta, Eduardo
    Lievens, Yolande
    Rodin, Danielle
    Mohamad, Osama
    JCO GLOBAL ONCOLOGY, 2023, 9
  • [47] Toxicity Profile in Postoperative Radiotherapy for Prostate Cancer with Moderate Hypofractionation
    Pacifico, P.
    Bonetto, E. M.
    Niespolo, R. M.
    De Ponti, E.
    Vukcaj, S.
    Arcangeli, S.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S610 - S610
  • [48] Does sufficient evidence exist to support hypofractionation for prostate cancer?
    Carlone, M
    Wilkins, D
    Raaphorst, P
    RADIOTHERAPY AND ONCOLOGY, 2004, 72 : S15 - S15
  • [49] Hypofractionation Adoption in Prostate Cancer Radiotherapy: Results of an International Survey
    Sabbagh, Ali
    Weiss, Jessica
    Tawk, Bouchra
    Mohammed, Mohammed A.
    Abdulbaki, Hasan
    Moraes, Fabio Y.
    Grover, Surbhi
    Yap, Mei Ling
    Zubizarreta, Eduardo
    Lievens, Yolande
    Rodin, Danielle
    Mohamad, Osama
    JCO GLOBAL ONCOLOGY, 2023, 9 : e2300046
  • [50] Moderate hypofractionation radiotherapy with helical tomotherapy (HT) for prostate cancer
    Ferrera, G.
    Mortellaro, G.
    Caminiti, G.
    Mazzola, R.
    Spera, A.
    Grillo, A.
    Di Paola, G.
    Cucchiara, T.
    Sciume, F.
    Messana, D.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S91 - S92
12345